Development and optimization of a methimazole microemulsion for topical application: Formulation characteristics and transdermal permeation
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Anayatollah Salimi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Hauptthemen laut MEDLINE: Emulsions, Methimazole, Skin Absorption, Administration, Cutaneous. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Methimazole, an oral antithyroid drug, has recently gained attention for its skin‐brightening effects when applied topically to treat melasma. This study aims to develop, optimize, and characterize a methimazole microemulsion as a novel, safe approach for local melasma treatment. Materials and Methods We prepared microemulsion formulations containing 3% methimazole by combining appropriate amounts of surfactants (Tween 80 and Span 20), propylene glycol cosurfactant, and an oil phase (oleic acid‐transcutol p at a 1:10 ratio). We then assessed droplet size, stability, viscosity, and skin permeation using rat skin models.
Results
The microemulsions' droplet sizes ranged from 7.06 to 28.13 nm, with viscosities between 120 and 254 centipoises. Our analysis identified droplet size, viscosity, and membrane release as significant independent variables. We determined the permeability parameters of the optimal formulation through rat skin, including steady‐state permeability rate (J ss ), permeability coefficient (p), lag time (T lag ), and apparent diffusion coefficient (D app ).
Conclusion
We found that the microemulsions' characteristics, physicochemical properties, and in vitro release depended on the surfactant‐to‐cosurfactant ratio, water content, and oil content. We developed an optimal formulation with a high surfactant‐to‐cosurfactant ratio and low water and oil percentages. This formulation shows potential for commercialization and manufacturing of final products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Nanotechnology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Clinical Research Development Centre, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Anayatollah Salimi, Saeed Mohammad Soleymani
Zitieren
APA
Salimi, A., Hoseinzadeh, H., & Mohammad Soleymani, S. (2024). Development and optimization of a methimazole microemulsion for topical application: Formulation characteristics and transdermal permeation. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16528
Vancouver
Salimi A, Hoseinzadeh H, Mohammad Soleymani S. Development and optimization of a methimazole microemulsion for topical application: Formulation characteristics and transdermal permeation. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16528
BibTeX
@article{Salimi2024,
author = {Salimi, Anayatollah and Hoseinzadeh, Hadis and Mohammad Soleymani, Saeed},
title = {Development and optimization of a methimazole microemulsion for topical application: Formulation characteristics and transdermal permeation},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16528}
}
EUVIMED